Paragangliomas Recruiting Phase 2 Trials for Lanreotide (DB06791)

Also known as: Paraganglioma / Paraganglion neoplasm / Paraganglion neoplasm NOS / Neoplasm of paraganglion (disorder) / [M]Paraganglioma NOS (morphologic abnormality) / Gangliocytic paraganglioma (disorder) / Gangliocytic paraganglioma (morphologic abnormality) / Paraganglioma (morphologic abnormality) / Paraganglioma (disorder)

IndicationStatusPhase
DBCOND0051744 (Paragangliomas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03946527LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)Treatment